AviadoBio’s breakthrough therapy hopes to stop progress of FTD, which is usually diagnosed in people under 65
View the article
in SV News
AviadoBio’s breakthrough therapy hopes to stop progress of FTD, which is usually diagnosed in people under 65
We invest in talented innovators. We strongly adhere to the view that diversity, including under-represented groups, strongly adds to success. If you are an entrepreneur seeking investment and a partner who can help you to build your business, we would love to hear from you. Please get in contact with our team.